首页> 外文期刊>European urology >Erectile implants in female-to-male transsexuals: our experience in 129 patients.
【24h】

Erectile implants in female-to-male transsexuals: our experience in 129 patients.

机译:女性对男性变性者的勃起植入物:我们在129例患者中的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The combination of a neourethra and erection prosthesis in a single neophallus in the female-to-male transsexual remains a challenge. No good data are available on this subject. OBJECTIVE: To report the outcome in 129 female-to-male transsexuals with a neophallus after the implantation of an erectile prosthesis. DESIGN, SETTING, AND PARTICIPANTS: From March 1996 until October 2007, 129 female-to-male transsexuals with a neophallus underwent the implantation of an erectile prosthesis. The mean follow-up was 30.2 mo (range: 0-132 mo). INTERVENTION: A Dynaflex prosthesis was implanted initially in 9 patients, a three-piece hydraulic device (AMS CX or AMS CXM) in 50 patients, and a CX Inhibizone, Ambicor, and Coloplast/Mentor prosthesis in 17, 47, and 6 patients, respectively. MEASUREMENTS: Data on outcome in these patients were retrospectively evaluated. RESULTS AND LIMITATIONS: Of 129 patients, 76 patients (58.9%) still have their original implant in place. Fifty-three patients (41.1%) needed to undergo either removal or revision of the prosthesis due to infection, erosion, dysfunction, or leak. Forty-one patients underwent a replacement of the prosthesis, nine needed a second revision, five needed a third revision, and one patient needed a fourth revision of prosthesis. Malposition of prosthesis was corrected by surgical repositioning so that removal or revision could be avoided. Of 185 prostheses used in 129 patients, 108 (58.4%) still remain in place, with a total infection rate of 11.9%, a total protrusion rate of 8.1%, a total prosthesis leak rate of 9.2%, a total dysfunction rate of 13%, and a total malposition rate of 14.6%. The period of follow-up in the more recent types of prostheses (Ambicor, Coloplast/Mentor) is much shorter; therefore, comparison with earlier types is difficult to make. CONCLUSIONS: Despite high complication rates, implantation of a hydraulic erectile prosthesis remains the best option for achieving the possibility of sexual intercourse in female-to-male transsexuals.
机译:背景:在女性对男性的变性者中,单个尿道中新尿道和勃起假体的结合仍然是一个挑战。没有关于此主题的良好数据。目的:报告129例男性勃起假体植入后的雌性至男性变性者的结局。设计,地点和参加者:从1996年3月到2007年10月,有129具新卵石的女性对男性变性者进行了勃起假体的植入。平均随访时间为30.2 mo(范围:0-132 mo)。干预措施:9例患者最初植入Dynaflex假体,50例患者使用三件式液压装置(AMS CX或AMS CXM),17,47和6例患者中植入CX Inhibizone,Ambicor和Coloplast / Mentor假体,分别。测量:对这些患者的结局数据进行回顾性评估。结果与局限性:在129例患者中,有76例(58.9%)仍保留了其原始植入物。由于感染,糜烂,功能障碍或渗漏,有53名患者(41.1%)需要进行假体切除或翻修。 41位患者进行了假体置换,其中9位需要进行第二次修订,五位需要进行第三次修订,一名患者需要进行第四次修复。通过外科手术重新定位假体的位置不正确,从而可以避免移除或翻修。在129例患者中使用的185个假体中,仍有108个(58.4%)保留在原位,总感染率为11.9%,总突出率为8.1%,总假体漏出率为9.2%,总功能障碍率为13 %,总错位率为14.6%。在较新类型的假体(Ambicor,Coloplast / Mentor)中,随访时间要短得多。因此,很难与早期类型进行比较。结论:尽管并发症发生率很高,但水力勃起假体的植入仍然是实现女性对男性变性者性交的最佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号